Efficacy of Five Strategies To Improve Stroke Awareness in the Spanish-Speaking Population (NCT06613828) | Clinical Trial Compass
CompletedNot Applicable
Efficacy of Five Strategies To Improve Stroke Awareness in the Spanish-Speaking Population
Mexico435 participantsStarted 2024-04-01
Plain-language summary
The goal of this experimental study is to evaluate the efficacy of five educational strategies for recognizing early symptoms of cerebrovascular disease (CVD) in the general adult population. The main questions it aims to answer are:
\- How effective are the strategies RAPIDO, CORRE, DALE, CAMALEON, and ICTUS 911 in improving the recognition of early CVD symptoms?
Researchers will compare these strategies to determine which one leads to the highest increase in symptom recognition. Participants will receive a brief educational session on one of the five strategies and will:
* Complete a pre- and post-intervention survey (Stroke Awareness Questionnaire, SAQ).
* Receive short training on CVD symptoms and the urgency of contacting emergency services.
The primary outcome is the improvement in SAQ scores, and the secondary outcome is the proportion of participants achieving adequate knowledge of CVD symptoms.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age: Participants must be 18 years or older.
* Consent: Participants must provide informed consent to participate in the study.
* General Population: Participants from the general public, regardless of their health insurance status or previous medical history (except as specified in exclusion criteria).
* Language: Participants must be fluent in Spanish, as the educational interventions are based on Spanish-language mnemonic strategies.
Exclusion Criteria:
* History of Stroke: Participants with a previous diagnosis of cerebrovascular disease (stroke) will be excluded.
* Cognitive Impairment: Participants who are unable to understand or complete the Stroke Awareness Questionnaire (SAQ) due to cognitive or communication impairments will not be eligible.
* Incomplete Evaluation: Participants who are unable to complete both the pre- and post-intervention assessments will be excluded from the study.
Elimination Criteria:
* Lack of Follow-Up: Participants who fail to attend the second evaluation (7 days post-intervention) will be excluded from the final analysis.
* Withdrawal of Consent: Participants who choose to withdraw from the study at any time will be eliminated from further participation.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in Stroke Awareness Questionnaire (SAQ) Score
Timeframe: Pre-intervention and 7 days post-intervention.